首页 › 基金 › Giverny Capital Inc. › RMD
Giverny Capital Inc. 对 RMD 的持仓历史
RESMED INC · 医疗保健
Giverny Capital Inc. 在 Q3 2026 的 13F 申报中披露持有 RMD(RESMED INC)369,970 股,市值约 US$81.8M,约占其申报组合的 2.80%,在其申报持仓中市值排名第 12 位。 Giverny Capital Inc. 最近 5 个申报季度中有 5 个季度披露了 RMD 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Giverny Capital Inc. 对 RMD 的持仓演变
Giverny Capital Inc. 于 Q3 2025 首次披露 RMD 持仓:235,418 股(约 US$64.4M)。 该持仓在 Q3 2026 达到峰值 369,970 股,市值约 US$81.8M。 在 5 次申报中,Giverny Capital Inc. 1 次增持、2 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 369,970 股、市值约 US$81.8M,环比减持 -17,695 股。。 持仓曾出现大幅变动:Q2 2026 增持约 69% (随后一个季度股价上涨 13%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 235.42K | $64.44M | 新进 |
| Q4 2025 | 235.39K | $56.70M | 持有 |
| Q1 2026 | 230.00K | $51.63M | 减持 |
| Q2 2026 | 387.67K | $75.55M | 增持 |
| Q3 2026 | 369.97K | $81.80M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RMD 与 13F 数据
RMD(RESMED INC)属于医疗保健行业。我们追踪的基金中还有 31 只申报持有 RMD,申报仓位最大的包括:Ilex Capital Partners (UK) LLP (US$163.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Giverny Capital Inc.
常见问题
How long has Giverny Capital Inc. held RMD?
Giverny Capital Inc. has disclosed RMD holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Giverny Capital Inc.'s current position in RMD?
As of Q3 2026, Giverny Capital Inc. holds 369.97K shares of RMD (RESMED INC), valued at $81.80M, representing 2.80% of its reported portfolio and ranking #12.
Has Giverny Capital Inc. been buying or selling RMD?
In the latest 13F filing (Q3 2026), Giverny Capital Inc. reduced its position in RMD. The position peaked in Q3 2026 at 369.97K shares.
Which other funds hold RMD?
Other major institutional holders of RMD include Ilex Capital Partners (UK) LLP, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.